I'm all for expanding product line and tapping into new and different industries that could use cbd products, that's growth. But they are doing too much, too fast. They are just incurring more and more expenses... R&D, manufacturing, list goes on. They should be focusing on the products they have currently at market to reduce expenditure and close the gap between costs and revenue. They keep going on like this, we'll never see a positive balance sheet.
Until they become more than a micro-cap stock, they should be working toward profitability but at this rate of product expansion they won't turn a profit for a very long time.
IMO.
CPH Price at posting:
17.3¢ Sentiment: Hold Disclosure: Held
